These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9751696)

  • 21. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.
    Pilotto JH; Velasque LS; Friedman RK; Moreira RI; Veloso VG; Grinsztejn B; Morgado MG; Watts DH; Currier JS; Hoffman RM
    Antivir Ther; 2011; 16(3):349-56. PubMed ID: 21555817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials.
    Rasmussen TA; Tolstrup M; Winckelmann A; Østergaard L; Søgaard OS
    Hum Vaccin Immunother; 2013 Apr; 9(4):790-9. PubMed ID: 23563519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
    Ngemu EK; Khayeka-Wandabwa C; Kweka EJ; Choge JK; Anino E; Oyoo-Okoth E
    BMC Res Notes; 2014 Jan; 7():52. PubMed ID: 24447387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.
    Chun TW; Engel D; Berrey MM; Shea T; Corey L; Fauci AS
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8869-73. PubMed ID: 9671771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The number of HIV DNA-infected mononuclear cells is reduced under HAART plus recombinant IL-2. IRHAN Study Group.
    Dianzani F; Antonelli G; Aiuti F; Turriziani O; Riva E; Capobianchi MR; Pandolfi F; D'Offizi G
    Antiviral Res; 2000 Feb; 45(2):95-9. PubMed ID: 10809018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latent reservoirs of HIV: obstacles to the eradication of virus.
    Chun TW; Fauci AS
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):10958-61. PubMed ID: 10500107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of combination antiretroviral therapy in pregnant women with HIV disease.
    Newshan G; Hoyt MJ
    MCN Am J Matern Child Nurs; 1998; 23(6):307-12; quiz 313. PubMed ID: 9819522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Mother-to-Child Transmission Study in Nigeria: The Impact of Maternal HIV Infection and HAART on Plasma Immunoglobulins, Cytokine Profiles and Infant Outcome.
    Ewenighi-Amankwah CO; Onyenekwe CC; Udemba O; Muogbo P; Rong L
    Virol Sin; 2020 Aug; 35(4):468-477. PubMed ID: 32157604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 infection of monocytes is directly related to the success of HAART.
    Almodóvar S; Del C Colón M; Maldonado IM; Villafañe R; Abreu S; Meléndez I; Domínguez C; Cuevas W; Collins TM; Lorenzo E
    Virology; 2007 Dec; 369(1):35-46. PubMed ID: 17707072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation.
    Li P; Kaiser P; Lampiris HW; Kim P; Yukl SA; Havlir DV; Greene WC; Wong JK
    Nat Med; 2016 Jul; 22(7):807-11. PubMed ID: 27294875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.
    Pincus SH; Song K; Maresh GA; Frank A; Worthylake D; Chung HK; Polacino P; Hamer DH; Coyne CP; Rosenblum MG; Marks JW; Chen G; Weiss D; Ghetie V; Vitetta ES; Robinson JE; Hu SL
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27795412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virus.
    Davey RT; Boenning CM; Herpin BR; Batts DH; Metcalf JA; Wathen L; Cox SR; Polis MA; Kovacs JA; Falloon J
    J Infect Dis; 1994 Nov; 170(5):1180-8. PubMed ID: 7963711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal time on HAART for prevention of mother-to-child transmission of HIV.
    Chibwesha CJ; Giganti MJ; Putta N; Chintu N; Mulindwa J; Dorton BJ; Chi BH; Stringer JS; Stringer EM
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):224-8. PubMed ID: 21709566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
    Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
    Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mother-to-child HIV transmission and ARVs.
    de Vlas SJ; Nagelkerke NJ; Jha P; Plummer FA
    Science; 2002 Dec; 298(5601):2129. PubMed ID: 12481779
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents.
    Petravic J; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP
    J Virol; 2017 May; 91(9):. PubMed ID: 28202759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.